When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result? Based on new findings published in the American Journal of Medicine, Michigan State University researchers are answering that question in no uncertain terms. "The message to doctors is clear: Take the chance," said Paul D. Stein, a professor in MSU's Department of Osteopathic Medical Specialties...
More...
More...